Cryoport Inc
Change company Symbol lookup
Select an option...
CYRX Cryoport Inc
CZR Caesars Entertainment Inc
UNP Union Pacific Corp
UIHC United Insurance Holdings Corp
BLFE Biolife Sciences Inc
GRPN Groupon Inc
AINV Apollo Investment Corp
NVRO Nevro Corp
MSFT Microsoft Corp
RLGMF West Red Lake Gold Mines Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services the Company enable its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions.

Closing Price
$47.34
Day's Change
-1.63 (-3.33%)
Bid
--
Ask
--
B/A Size
--
Day's High
49.89
Day's Low
46.95
Volume
(Below Average)
Volume:
631,659

10-day average volume:
754,427
631,659

Display:

Providers:

UpdateCancel
6 providers
November 05, 2020
CryoPort, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 5, 2020 / CryoPort, Inc. (NASDAQ:CYRX) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 5, 2020 at 5:00 PM Eastern Time. (Accesswire)

November 02, 2020
Petrichor Closes Oversubscribed Fund I at $410 Million

Petrichor Healthcare Capital Management ("Petrichor"), a private equity firm that makes structured investments in the healthcare sector, today announced the final close of Petrichor Opportunities Fund I, LP which was oversubscribed with $410 million...(BusinessWire)

October 29, 2020
Cryoport to Report Third Quarter 2020 Financial Results on November 5, 2020

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in life sciences solutions, today announced that the Company will report financial results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020...(PR Newswire)

October 01, 2020
Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), the life sciences industry's preeminent partner for temperature-controlled supply chain solutions, today announced it has completed the acquisitions of MVE Biological Solutions ("MVE"), a...(PR Newswire)

Chart Industries Expands Liquid Hydrogen and LNG Business with Strategic Agreements

Chart Industries, Inc. ("Chart") (NASDAQ: GTLS) today completed the previously announced divestiture of its cryobiological products business (MVE Biological Products) to Cryoport, Inc. ("Cryoport") (NASDAQ: CYRX) for $320 million in cash. (Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.